Alumis Inc Common Stock
Price & Volume
Stats
See more52W Range | $4.36-$16 |
Market Cap | $630.5M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.48 |
News
See moreYahoo Finance • 5 days ago
Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis
Yahoo Finance • 9 days ago
Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger
Yahoo Finance • 9 days ago
ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger
About
CEO | Mr. Martin Babler Ph.D. |
Address | 280 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 145 |
